Antioxidants As a Novel Treatment to Revert Impaired Angiogenic Potential Driven By Metabolic Alterations Observed in Shwachman-Diamond Syndrome Derived Mesenchymal Stromal Cells

MLA

Gervasoni, Clarissa, et al. “Antioxidants As a Novel Treatment to Revert Impaired Angiogenic Potential Driven By Metabolic Alterations Observed in Shwachman-Diamond Syndrome Derived Mesenchymal Stromal Cells.” Blood, vol. 142, no. 1, Number 1 Supplement 1, Nov. 2023, p. 4106. EBSCOhost, https://doi.org/10.1182/blood-2023-181932.

APA

Gervasoni, C., Bertola, N., Giussani, A. M., Dander, E., Bezzerri, V., Biondi, A., Corti, P., Farruggia, P., Giagnuolo, G., Menna, G., Pegoraro, A., Cesaro, S., Cipolli, M., Dufour, C., Ravera, S., & D’Amico, G. (2023). Antioxidants As a Novel Treatment to Revert Impaired Angiogenic Potential Driven By Metabolic Alterations Observed in Shwachman-Diamond Syndrome Derived Mesenchymal Stromal Cells. Blood, 142(1, Number 1 Supplement 1), 4106. https://doi.org/10.1182/blood-2023-181932

Chicago

Gervasoni, Clarissa, Nadia Bertola, Alice Martina Giussani, Erica Dander, Valentino Bezzerri, Andrea Biondi, Paola Corti, et al. 2023. “Antioxidants As a Novel Treatment to Revert Impaired Angiogenic Potential Driven By Metabolic Alterations Observed in Shwachman-Diamond Syndrome Derived Mesenchymal Stromal Cells.” Blood 142 (1, Number 1 Supplement 1): 4106. doi:10.1182/blood-2023-181932.